Personal information

Activities

Collapse all

Employment (3)

Johns Hopkins University: Baltimore, MD, US

2017-07-01 to present | Assistant Professor (Biomedical Engineering and Chemical & Biomolecular Engineering)
Employment
Source: Self-asserted source
Jamie Spangler

Stanford University: Stanford, CA, US

2011-07 to 2017-06 | Postdoctoral Scholar (Molecular & Cellular Physiology)
Employment
Source: Self-asserted source
Jamie Spangler

National Institute of Allergy and Infectious Diseases: Bethesda, MD, US

2006-01 to 2006-08 | Post-Baccalaureate Research Fellow (Molecular Virology)
Employment
Source: Self-asserted source
Jamie Spangler

Education and qualifications (2)

Massachusetts Institute of Technology: Cambridge, MA, US

2006-09 to 2011-06 | PhD (Biological Engineering)
Education
Source: Self-asserted source
Jamie Spangler

Johns Hopkins University: Baltimore, MD, US

2002-09 to 2006-06 | BS (Biomedical Engineering)
Education
Source: Self-asserted source
Jamie Spangler

Funding (2)

Immunotherapeutic cytokine/antibody fusion proteins to treat melanoma

2021-06-01 to 2024-05-31 | Grant
Melanoma Research Alliance (Washington, DC, US)
GRANT_NUMBER:

824779
Source: check_circle
ProposalCentral

Modulating T cell homeostasis via structure-based engineering of IL-23 variants

2012-07 to 2015-06 | Award
Leukemia and Lymphoma Society (NY, NY, US)
GRANT_NUMBER:

5733-13
Source: Self-asserted source
Jamie Spangler

Peer review (59 reviews for 28 publications/grants)

Review activity for ACS applied bio materials. (1)
Review activity for ACS chemical biology. (1)
Review activity for ACS nano. (2)
Review activity for ACS synthetic biology. (5)
Review activity for Bioconjugate chemistry. (1)
Review activity for Cancer cell. (2)
Review activity for Cell chemical biology. (2)
Review activity for Cell reports medicine. (4)
Review activity for Cell reports. (1)
Review activity for Cell. (1)
Review activity for Cellular and molecular bioengineering. (4)
Review activity for Gene therapy. (1)
Review activity for Journal for immunotherapy of cancer. (5)
Review activity for Journal of Molecular Biology. (1)
Review activity for Molecular pharmaceutics. (1)
Review activity for Molecular therapy (4)
Review activity for Nature (2)
Review activity for Nature biomedical engineering. (1)
Review activity for Nature cancer. (1)
Review activity for Nature Catalysis. (1)
Review activity for Nature chemical biology. (5)
Review activity for Nature communications (6)
Review activity for Nature methods. (1)
Review activity for Nature nanotechnology (1)
Review activity for Nature reviews. (2)
Review activity for Signal transduction and targeted therapy. (1)
Review activity for Trends in molecular medicine. (1)
Review activity for Trends in pharmacological sciences. (1)
How many people are using ORCID?